Characterizing Endocannabinoid System Alterations to Inform Novel Therapeutic Targets
- Exploring endocannabinoid system alterations, potentially contributing to heightened stress reactivity and increased risk of relapse in opioid-use disorder
- Establishing clinical relevance and exploring endocannabinoid modulation as a treatment strategy
- Understanding what population is a better target to use in a clinical trial for endocannabinoid system modulation